|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910781663003321 |
|
|
Titolo |
Pharmaceutical industry [[electronic resource] ] : innovation and developments / / David A. Mancuso and Isobel M. Grenada, editors |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Hauppauge, N.Y., : Nova Science, c2011 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (194 p.) |
|
|
|
|
|
|
Collana |
|
Business issues, competition and entrepreneurship |
Pharmacology-research, safety testing and regulation |
|
|
|
|
|
|
|
|
Altri autori (Persone) |
|
MancusoDavid A |
GrenadaIsobel M |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Drug development |
Pharmaceutical industry |
Drugs - Law and legislation |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO. |
|
|
|
|
|
|
|